Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1. Adverum granted stock options and RSUs to new employees. 2. Stock options cover 16,860 shares with an exercise price of $3.08. 3. RSUs granted for 8,430 shares, vesting over three years. 4. Adverum focuses on gene therapy for ocular diseases' treatment. 5. Ixo-vec targets neovascular age-related macular degeneration through IVT.